Cargando…

Comment on Pancreatitis in Type 1 Tyrosinemia

Detalles Bibliográficos
Autores principales:	Rahmoune, Hakim, Boutrid, Nada, Amrane, Mounira, Bioud, Belkacem
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Galenos Publishing 2017
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5615974/ https://www.ncbi.nlm.nih.gov/pubmed/28783026 http://dx.doi.org/10.4274/balkanmedj.2016.1209

Ejemplares similares

Letter to the Editor: Morphea, Gluten, and Autoimmunity: HLA Behind the Scenes?
por: Boutrid, Nada, et al.
Publicado: (2021)

Ataxia in children: think about vitamin E deficiency ! (comment on: ataxia in children: early recognition and clinical evaluation)
por: Rahmoune, H., et al.
Publicado: (2017)

67 Double impact: hypophosphatemic rickets and vitamin D intoxication
por: Boutrid, N, et al.
Publicado: (2022)

40 Arthralgia and celiac disease
por: Boutrid, N, et al.
Publicado: (2022)

64 Conical teeth? Think outside the box!
por: Boutrid, N, et al.
Publicado: (2022)

73 Joint pains revealing a dysautonomic syndrome
por: Boutrid, N, et al.
Publicado: (2022)

74 Hereditary angioedema revealed by compartment syndrome
por: Boutrid, N, et al.
Publicado: (2022)

Migraine, Celiac Disease and Intestinal Microbiota
por: Rahmoune, Hakim, et al.
Publicado: (2017)

Autism & Gluten: The Proof By Regression!
por: Rahmoune, Hakim, et al.
Publicado: (2018)

Gestational Diabetes Mellitus: increased incidence during the COVID-19 pandemic
por: Boutrid, Hala, et al.
Publicado: (2022)

Phenotype, genotype, and outcome of 25 Palestinian patients with hereditary tyrosinemia type 1
por: Dweikat, Imad, et al.
Publicado: (2021)

Treatment adherence in tyrosinemia type 1 patients
por: González-Lamuño, Domingo, et al.
Publicado: (2021)

Hepatorenal tyrosinemia
por: KITAGAWA, Teruo
Publicado: (2012)

Tyrosinemia type III in an asymptomatic girl
por: Szymanska, Edyta, et al.
Publicado: (2015)

Persistent coagulopathy during Streptococcus pneumoniae sepsis and left foot abscess in a previously healthy infant revealed tyrosinemia
por: Liu, Bing, et al.
Publicado: (2021)

Type 1 tyrosinemia in Finland: a nationwide study
por: Äärelä, Linnea, et al.
Publicado: (2020)

Case report: ADHD and prognosis in tyrosinemia type 1
por: Barone, Helene, et al.
Publicado: (2023)

Severe neurological crisis in adult patients with Tyrosinemia type 1
por: Dawson, Charlotte, et al.
Publicado: (2020)

Revisiting hereditary tyrosinemia Type 1—spectrum of radiological findings
por: Shaikh, Sana, et al.
Publicado: (2018)

Hereditary Tyrosinemia Type 1 in Jordan: A Retrospective Study
por: Megdadi, Noor A., et al.
Publicado: (2021)

Syndrome of hereditary tyrosinemia in mink
por: Christensen, K, et al.
Publicado: (1978)

Neurocognitive outcome in tyrosinemia type 1 patients compared to healthy controls
por: van Ginkel, Willem G., et al.
Publicado: (2016)

Evolution of tyrosinemia type 1 disease in patients treated with nitisinone in Spain
por: Couce, María Luz, et al.
Publicado: (2019)

Comments on Post‐pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes
por: Yi, Jin‐Hui, et al.
Publicado: (2023)

Clinical utility of nitisinone for the treatment of hereditary tyrosinemia type-1 (HT-1)
por: Das, Anibh Martin
Publicado: (2017)

Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer'
por: Badrick, Ellena, et al.
Publicado: (2016)

Comment on Andersen et al, Pancreatitis–Diabetes–Pancreatic Cancer: Summary of an NIDDK-NCI Workshop
por: Moses, Alan Charles, et al.
Publicado: (2014)

Reply to ‘Comment on ‘New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer''
por: Lu, Yunxia, et al.
Publicado: (2016)

Casein Glycomacropeptide: An Alternative Protein Substitute in Tyrosinemia Type I
por: Daly, Anne, et al.
Publicado: (2021)

Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1
por: Li, Li, et al.
Publicado: (2017)

Long-Term Outcomes and Practical Considerations in the Pharmacological Management of Tyrosinemia Type 1
por: van Ginkel, Willem G., et al.
Publicado: (2019)

Biomarkers of Micronutrients in Regular Follow-Up for Tyrosinemia Type 1 and Phenylketonuria Patients
por: van Vliet, Kimber, et al.
Publicado: (2019)

Comment on “Updated meta-analysis of pancreatic stent placement in preventing post-endoscopic retrograde cholangiopancreatography pancreatitis”
por: Chu, Jiang-Tao
Publicado: (2020)

Comments on Post‐pancreatitis diabetes mellitus is common in chronic pancreatitis and is associated with adverse outcomes: Authors' reply
por: Dugic, Ana, et al.
Publicado: (2023)

Reply: ‘Comments on Stromal disrupting effects of nab-paclitaxel in pancreatic cancer'
por: Alvarez, R, et al.
Publicado: (2014)

Comments on “The beneficial role of electrochemotherapy in locally advanced pancreatic cancer – radiological perspective”
por: Granata, Vincenza, et al.
Publicado: (2022)

A Case of Tyrosinemia Type III with Status Epilepticus and Mental Retardation
por: Najafi, Reza, et al.
Publicado: (2018)

TYROSINEMIA TYPE III: A CASE REPORT OF SIBLINGS AND LITERATURE REVIEW
por: Barroso, Fábio, et al.
Publicado: (2020)

Therapeutic Targeting of Fumaryl Acetoacetate Hydrolase in Hereditary Tyrosinemia Type I
por: Gil-Martínez, Jon, et al.
Publicado: (2021)

Tyrosinemia type 1: a rare and forgotten cause of reversible hypertrophic cardiomyopathy in infancy
por: Mohamed, Sarar, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_rvjvvlnvtpvi7gubarjj6esv8k